Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 151853quant Healthcare Fund
Disclosed for 38 months, Aug 2023 to Sep 2026.
Portfolio value
₹402 Cr
down ₹21.5 Cr vs Dec 2024
- Stocks held
- 15
- down 6 vs Dec 2024
- Top 10 weight
- 73.8%
- of the portfolio in its ten largest
- Cash & debt
- 1.9%
- cash, money market and debt
quant Healthcare Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In January 2025 it disclosed 15 stocks worth ₹402 Cr, down ₹21.5 Cr from Dec 2024. Its largest positions were RPG Life Sciences Limited (9.3%), Aster DM Healthcare Limited (8.6%), Divi's Laboratories Limited (8.5%); the ten largest together made up 73.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 69.3% of its equity. Cash and debt stood at 1.9%. Compared with Dec 2024 the fund entered 1 new stock and exited 7.
Against 229 other Sectoral / Thematic funds
Concentration
95%
Top-10 weight is higher than 95% of peers
Breadth
2%
Holds more stocks than 2% of peers
Cash
28%
Holds more cash than 28% of peers
What these mean: concentration · cash
Holdings in January 2025
Download CSVEvery line the fund disclosed, with the change against Dec 2024. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| RPG Life Sciences Limited | 9.28% | up 1.40 pts | ₹37.4 Cr | up ₹3.9 Cr | Added |
| Aster DM Healthcare Limited | 8.61% | up 0.07 pts | ₹34.7 Cr | down ₹1.6 Cr | Trimmed |
| Divi's Laboratories Limited | 8.49% | up 8.49 pts | ₹34.2 Cr | up ₹34.2 Cr | New |
| Glenmark Life Sciences Limited | 7.34% | up 1.63 pts | ₹29.6 Cr | up ₹5.3 Cr | Added |
| Zydus Lifesciences Limited | 7.06% | up 0.60 pts | ₹28.4 Cr | up ₹1 Cr | Added |
| Reliance Industries Limited | 6.87% | up 0.61 pts | ₹27.7 Cr | up ₹1.1 Cr | Added |
| Torrent Pharmaceuticals Limited | 6.80% | up 4.36 pts | ₹27.4 Cr | up ₹17 Cr | Added |
| IPCA Laboratories Limited | 6.55% | down 0.28 pts | ₹26.4 Cr | down ₹2.6 Cr | Trimmed |
| Pfizer Limited | 6.47% | down 0.68 pts | ₹26 Cr | down ₹4.3 Cr | Trimmed |
| Aurobindo Pharma Limited | 6.33% | down 0.51 pts | ₹25.5 Cr | down ₹3.5 Cr | Trimmed |
| Zydus Wellness Limited | 5.86% | down 0.11 pts | ₹23.6 Cr | down ₹1.7 Cr | Trimmed |
| HFCL Limited | 5.82% | down 0.53 pts | ₹23.4 Cr | down ₹3.5 Cr | Trimmed |
| Sequent Scientific Limited | 5.52% | down 0.06 pts | ₹22.2 Cr | down ₹1.4 Cr | Trimmed |
| SMS Pharmaceuticals Limited | 3.32% | down 0.41 pts | ₹13.4 Cr | down ₹2.5 Cr | Trimmed |
| Suraksha Diagnostic Limited | 2.62% | down 0.40 pts | ₹10.5 Cr | down ₹2.2 Cr | Trimmed |
| 91 Days Treasury Bills Debt | 2.45% | up 2.45 pts | ₹9.9 Cr | up ₹9.9 Cr | New |
| 91 Days Treasury Bill 21-Feb-2025 Debt | 1.24% | up 0.07 pts | ₹5 Cr | up ₹3 L | Added |
| Dr. Reddy's Laboratories Limited 27/02/2025 Derivative | 1.16% | up 1.16 pts | ₹4.6 Cr | up ₹4.6 Cr | New |
| Cash, TREPS & receivables | −1.79% | down 1.52 pts | −₹7.2 Cr | down ₹6 Cr | Trimmed |
What changed, Dec 2024 to Jan 2025
New New positions (1)
- Divi's Laboratories Limited8.5% · ₹34.2 Cr
Exited Exited (7)
- GlaxoSmithKline Pharmaceuticals Limitedwas 5.4% · ₹22.7 Cr
- Aarti Pharmalabs Limitedwas 4.5% · ₹19.3 Cr
- Suven Life Sciences Limitedwas 2.5% · ₹10.6 Cr
- Alembic Pharmaceuticals Limitedwas 1.0% · ₹4.3 Cr
- Sanofi Consumer Healthcare India Limitedwas 0.9% · ₹3.9 Cr
- Acutaas Chemicals Limitedwas 0.9% · ₹3.8 Cr
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2024, the weight rose most in Pharmaceuticals & Biotechnology (+3.2 pts) and Petroleum Products (+0.8 pts), and fell most in Healthcare Services (−3.5 pts) and Telecom - Services (−0.4 pts).
- Pharmaceuticals & Biotechnology66.1% → 69.3%+3.2 pts
- Petroleum Products6.3% → 7.1%+0.8 pts
- Healthcare Services15.1% → 11.6%−3.5 pts
- Telecom - Services6.4% → 6.0%−0.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2024 | Jul 2024 | Oct 2024 | Dec 2024 | Jan 2025 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 58.1% | 75.1% | 68.9% | 66.1% | 69.3% |
| Healthcare Services | 5.2% | 8.7% | 10.9% | 15.1% | 11.6% |
| Petroleum Products | 13.4% | — | 7.3% | 6.3% | 7.1% |
| Food Products | — | 7.2% | 6.0% | 6.0% | 6.0% |
| Telecom - Services | — | — | 6.9% | 6.4% | 6.0% |
Allocation in Jan 2025change vs Dec 2024
- Pharmaceuticals & Biotechnology (10)69.3%▲ 3.2 pts
- Healthcare Services (2)11.6%▼ 3.5 pts
- Petroleum Products (1)7.1%▲ 0.8 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jan 2025
1.9%
▲ 1.0 pts vs Dec 2024
- Cash alone
- −1.8%
- cash and net receivables
- A year earlier
- 5.8%
- Jan 2024 · now ▼ 3.9 pts
- Last 12 months
- 0.4% – 7.5%
- lowest to highest · record 7.5% in Feb 2024
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.